Meiji Yasuda Life Insurance’s Biogen BIIB Stock Holding History

Meiji Yasuda Life Insurance’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,401	Closed	-$360K	–	263
2023 Q3	$360K	Hold	1,401	–	–	0.01%	229
2023 Q2	$399K	Buy	1,401 +50	+4%	+$14.9K	0.01%	228
2023 Q1	$376K	Hold	1,351	–	–	0.01%	236
2022 Q4	$374K	Sell	1,351 -600	-31%	-$169K	0.01%	243
2022 Q3	$521K	Hold	1,951	–	–	0.01%	205
2022 Q2	$398K	Hold	1,951	–	–	0.01%	214
2022 Q1	$411K	Sell	1,951 -557	-22%	-$121K	0.01%	219
2021 Q4	$602K	Sell	2,508 -422	-14%	-$109K	0.01%	201
2021 Q3	$829K	Sell	2,930 -190	-6%	-$62.3K	0.01%	172
2021 Q2	$1.08M	Buy	3,120 +35	+1%	+$10.6K	0.02%	148
2021 Q1	$863K	Hold	3,085	–	–	0.02%	159
2020 Q4	$755K	Sell	3,085 -1,441	-32%	-$372K	0.01%	166
2020 Q3	$1.28M	Buy	4,526 +411	+10%	+$115K	0.03%	131
2020 Q2	$1.1M	Buy	4,115 +62	+2%	+$18.6K	0.04%	134
2020 Q1	$1.28M	Sell	4,053 -793	-16%	-$241K	0.26%	99
2019 Q4	$1.44M	Sell	4,846 -790	-14%	-$219K	0.2%	129
2019 Q3	$1.31M	Sell	5,636 -81	-1%	-$18.9K	0.19%	131
2019 Q2	$1.34M	Buy	5,717 +377	+7%	+$87.1K	0.2%	126
2019 Q1	$1.26M	Sell	5,340 -619	-10%	-$195K	0.19%	131
2018 Q4	$1.79M	Sell	5,959 -827	-12%	-$264K	0.28%	89
2018 Q3	$2.4M	Buy	6,786 +230	+4%	+$79.2K	0.3%	83
2018 Q2	$1.9M	Buy	6,556 +590	+10%	+$166K	0.26%	102
2018 Q1	$1.63M	Sell	5,966 -610	-9%	-$189K	0.25%	106
2017 Q4	$2.1M	Buy	6,576 +210	+3%	+$67.4K	0.29%	89
2017 Q3	$1.99M	Sell	6,366 -500	-7%	-$148K	0.29%	90
2017 Q2	$1.86M	Buy	6,866 +1,300	+23%	+$344K	0.29%	89
2017 Q1	$1.52M	Buy	5,566 +200	+4%	+$56.5K	0.24%	109
2016 Q4	$1.52M	Sell	5,366 -1,510	-22%	-$448K	0.25%	99
2016 Q3	$2.15M	Sell	6,876 -740	-10%	-$219K	0.29%	94
2016 Q2	$1.84M	Buy	7,616 +220	+3%	+$58K	0.29%	99
2016 Q1	$1.93M	Buy	7,396 +700	+10%	+$185K	0.3%	90
2015 Q4	$2.05M	Hold	6,696	–	–	0.33%	85
2015 Q3	$1.95M	Sell	6,696 -1,110	-14%	-$367K	0.33%	87
2015 Q2	$3.15M	Hold	7,806	–	–	0.49%	48
2015 Q1	$3.3M	Sell	7,806 -1,804	-19%	-$711K	0.51%	45
2014 Q4	$3.26M	Buy	9,610 +520	+6%	+$168K	0.48%	43
2014 Q3	$3.01M	Buy	9,090 +1,265	+16%	+$417K	0.46%	43
2014 Q2	$2.47M	Buy	7,825 +113	+1%	+$34K	0.39%	55
2014 Q1	$2.36M	Sell	7,712 -333	-4%	-$106K	0.41%	48
2013 Q4	$2.25M	Buy	8,045 +300	+4%	+$77.6K	0.38%	58
2013 Q3	$1.86M	Sell	7,745 -69	-0.9%	-$15.4K	0.34%	68
2013 Q2	$1.68M	Buy	+7,814	New	+$1.67M	0.31%	73

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Meiji Yasuda Life Insurance's BIIB Position: Q4 2023 in Review

Meiji Yasuda Life Insurance sold out of Biogen (BIIB) in Q4 2023, closing a stake of 1,401 shares — an estimated $360K sold.

Meiji Yasuda Life Insurance first reported a position in BIIB in Q2 2013 and held it in 42 quarters. The position peaked at $3.3M in Q1 2015. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

Meiji Yasuda Life Insurance reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
Meiji Yasuda Life Insurance sold 1,401 Biogen shares in Q4 2023, an estimated $360K.
Meiji Yasuda Life Insurance first reported a position in Biogen in Q2 2013 and held it in 42 quarters.
Meiji Yasuda Life Insurance's Biogen position peaked at $3.3M in Q1 2015.
1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Meiji Yasuda Life Insurance's 13F filing for Q4 2023, filed 14 Feb 2024.